Literature DB >> 8248147

Expression of the human beta-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice.

B E Pearson1, T K Choi.   

Abstract

One hallmark of Alzheimer disease is the formation in the brain of amyloid plaques containing a small peptide derived from the beta-amyloid precursor protein (APP). The APP gene exhibits a complex pattern of expression in peripheral tissues and in the brain. The entire human APP gene was introduced into embryonic stem (ES) cells by co-lipofection of a 650-kb yeast artificial chromosome (YAC). Three ES lines containing an essentially intact YAC were isolated, and expression of human APP mRNAs at levels comparable to those of endogenous mouse APP transcripts was obtained. A transgenic mouse line was established by germ-line transmission of the APP YAC. RNase protection analysis of human APP mRNAs demonstrated appropriate splicing of the primary APP transcript in ES cells and in the brain of a transgenic animal. These mice may be useful for elucidating the function of the various APP isoforms in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248147      PMCID: PMC47820          DOI: 10.1073/pnas.90.22.10578

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Presenile dementia and Alzheimer's disease in mongolism.

Authors:  M I Olson; C M Shaw
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

2.  A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein.

Authors:  F de Sauvage; J N Octave
Journal:  Science       Date:  1989-08-11       Impact factor: 47.728

3.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

Authors:  B Rumble; R Retallack; C Hilbich; G Simms; G Multhaup; R Martins; A Hockey; P Montgomery; K Beyreuther; C L Masters
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

4.  Introns increase transcriptional efficiency in transgenic mice.

Authors:  R L Brinster; J M Allen; R R Behringer; R E Gelinas; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

Review 5.  Transgenic animals.

Authors:  R Jaenisch
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

6.  Structure and expression of the alternatively-spliced forms of mRNA for the mouse homolog of Alzheimer's disease amyloid beta protein precursor.

Authors:  T Yamada; H Sasaki; K Dohura; I Goto; Y Sakaki
Journal:  Biochem Biophys Res Commun       Date:  1989-02-15       Impact factor: 3.575

7.  Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease.

Authors:  M R Palmert; T E Golde; M L Cohen; D M Kovacs; R E Tanzi; J F Gusella; M F Usiak; L H Younkin; S G Younkin
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

8.  Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid, and lesioned mice.

Authors:  C Bendotti; G L Forloni; R A Morgan; B F O'Hara; M L Oster-Granite; R H Reeves; J D Gearhart; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.

Authors:  R E Tanzi; A I McClatchey; E D Lamperti; L Villa-Komaroff; J F Gusella; R L Neve
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

10.  Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

Authors:  G Giaccone; F Tagliavini; G Linoli; C Bouras; L Frigerio; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1989-02-13       Impact factor: 3.046

View more
  10 in total

1.  Lens defects and age-related fiber cell degeneration in a mouse model of increased AbetaPP gene dosage in Down syndrome.

Authors:  Peter H Frederikse; Xiao-Ou Ren
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

Review 3.  Size matters: use of YACs, BACs and PACs in transgenic animals.

Authors:  P Giraldo; L Montoliu
Journal:  Transgenic Res       Date:  2001-04       Impact factor: 2.788

Review 4.  Rodent models for Alzheimer's disease drug discovery.

Authors:  Daniela Puzzo; Walter Gulisano; Agostino Palmeri; Ottavio Arancio
Journal:  Expert Opin Drug Discov       Date:  2015-04-30       Impact factor: 6.098

Review 5.  Genetically engineered mice and their use in aging research.

Authors:  J K Andersen
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

Review 6.  Animal and model systems for studying cystic fibrosis.

Authors:  Bradley H Rosen; Marc Chanson; Lara R Gawenis; Jinghua Liu; Aderonke Sofoluwe; Alice Zoso; John F Engelhardt
Journal:  J Cyst Fibros       Date:  2017-09-19       Impact factor: 5.482

7.  Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier.

Authors:  A Baker; M Cotten
Journal:  Nucleic Acids Res       Date:  1997-05-15       Impact factor: 16.971

Review 8.  Alzheimer's disease: fundamental and therapeutic aspects.

Authors:  M Schorderet
Journal:  Experientia       Date:  1995-02-15

9.  Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.

Authors:  C D Link
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

10.  Faithful tissue-specific expression of the human chromosome 21-linked COL6A1 gene in BAC-transgenic mice.

Authors:  Luzhou Xing; Martha Salas; Chyuan-Sheng Lin; Warren Zigman; Wayne Silverman; Shivakumar Subramaniyam; Vundavalli V Murty; Benjamin Tycko
Journal:  Mamm Genome       Date:  2007-02-28       Impact factor: 3.224

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.